Introduction: Small-scale clinical studies with psychedelic drugs have shown promising
results for the treatment of several mental disorders. Before psychedelics become registered …

Psychedelics (serotonergic hallucinogens) are powerful psychoactive substances that alter
perception and mood and affect numerous cognitive processes. They are generally …

Background: Psilocybin, a psychoactive serotonin receptor partial agonist, has been
reported to acutely reduce clinical symptoms of depressive disorders. Psilocybin's effects on …

Background: On the current psychopharmacological panorama, the variety of substances
able to provoke an episode of acute psychosis is rapidly increasing. Such psychotic …

Hallucinogen Persisting Perception Disorder (HPPD) is a rare, and therefore, poorly
understood condition linked to hallucinogenic drugs consumption. The prevalence of this …

3, 4-Methylenedioxymethamphetamine (MDMA; ecstasy) is being investigated in MDMA-
assisted psychotherapy. The present study characterized the safety pharmacology of single …

Anxiety and depression are some of the most common psychiatric symptoms of patients
suffering with life-threatening diseases, often associated with a low quality of life and a poor …

Purpose of review: To summarize the literature on Alice in Wonderland syndrome (AIWS), a
disorder characterized by distortions of visual perception, the body schema, and the …

This chapter reviews what is known about the therapeutic uses of the serotonergic or classic
hallucinogens, ie, psychoactive drugs such as LSD and psilocybin that exert their effects …

Post-traumatic stress disorder (PTSD) is a debilitating mental illness with limited treatment
options and a high treatment dropout rate. Psychedelics, often in combination with …